📊 Get daily AI-graded market briefings
Morning + evening · AI impact + sector exposure · Free
LAST 30 DAYS
1 articles
AVG GRADE
HIGH
score: 0.50
SENTIMENT
BULLISH
TOTAL VIEWS
13
AKABY Latest News & AI Sentiment Analysis
1 articles · Grade: HIGH · Real-time AI-graded coverage
RECENT COVERAGE · 3 ARTICLES
ALK’s tree pollen and house dust mite tablets now recommended by NICE for paediatric treatment in the UK health system
ALK's immunotherapy tablets have received formal NICE recommendation for pediatric use in the UK, expanding their addressable market...
Invitation to the presentation of ALK’s first six months (Q2) 2026 results on Thursday, 20 August 2026
ALK (trading as AKABY and AKBLF on US exchanges) has announced a scheduled presentation of its H1 2026 financial results for Thursday,...
Market launch of the nasal adrenaline spray, neffy®, for treatment of adults and children with severe allergies in Canada
ALK-Ábelo announced the Canadian market launch of neffy®, a first-in-class nasal adrenaline spray for emergency anaphylaxis treatment....
E
ESEN Analytics
AI-powered equity research platform covering 5,000+ US equities. Our proprietary AI grading system (A+ to D scale) analyzes fundamentals, technicals, and news sentiment daily. Coverage data updated every 24 hours.
Learn about our methodology →
ⓘ AI-graded news coverage · Not investment advice